|
Files are in Adobe
format. 2011 CHEMICAL,
BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR SURVIVABILITY CONFERENCE “CBRN Survivability for Weapons Systems” Baltimore, MD 17 – 18 May 2011 TUESDAY, MAY 17, 2011 KEYNOTE SPEAKER ·
BG Jess Scarbrough, JPEO-CBD CBRN SURVIVABILITY
OVERVIEW · Ms. Helen Mearns, Joint CBRN Defense Program Analysis and Integration Office (PAIO) LABORATORY
INFRASTRUCTURE SUPPORT TO CBRN SURVIVABILITY CHAIRMAN OF THE JOINT CHIEFS OF STAFF INSTRUCTION (CJCSI) 3175.01
OVERVIEW · Mr. Mark Edwards, JRO-CBRND FUTURE CB ENSEMBLE / GROUND SOLDIER SYSTEM TECHNOLOGY (FCBE-GSS)
DEMONSTRATION PROGRAM · Andra Kirsteins, FCBE-GSS Demonstration Technology Manager CHEMICAL AND BIOLOGICAL MATERIAL EFFECTS (CBME) DATABASE · Mr. Chris Hill, U.S. Army Research Laboratory Survivability/Lethality Analysis Directorate (ARL/SLAD) WEDSDAY,
MAY 18, 2011 KEYNOTE SPEAKER ·
Dr. John Kuspa, Office of the
Deputy to the Assistant Secretary of Defense for Nuclear Matters (DATSD/NM) NUCLEAR SURVIVABILITY ·
Mr. John Franco, DTRA CBRN TEST INFRASTRUCTURE – TEST
RESEARCH MANAGEMENT CENTER · Dr. Suzanne Strohl,
Deputy Director, Strategic Planning, Office of the Secretary of Defense, Test
Resource Management Center OVERVIEW OF JPEO-CBD JOINT PROGRAM
MANAGERS (JPMS) · Representatives from JPM-CA,
JPM-IS, JPM-CBMS, JPM-G, CBRN SURVIVABILITY INFORMATION AND
ANALYSIS · Mr. Jerry Glasow,
Chief, Information and Analysis Division, within the Chemical and Biological
Directorate of the Joint Science and
Technology Office for CB Defense CURRENT EFFORTS TO IMPROVE CHEMICAL
CHALLENGE ESTIMATES · Dr. Jeffrey H. Grotte, Deputy Division Director of the Strategy,
Forces, and Resources Division at the Institute for Defense Analyses BREAKOUT SESSIONS · CBRN Survivability Oversight Group (CSOG) Action
Officers from the Navy, Air
Force, and Marine Corps Back to NDIA Conference Proceedings
BACK to the DTIC
Homepage
|
|
||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||